Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-21 Purchase |
2022-09-22 10:01 am |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
5,000 | $1.76 | $8,800 | 150,687 (Direct) |
View |
| 2022-05-20 Purchase |
2022-05-23 10:00 am |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
5,000 | $2.0398 | $10,199 | 138,525 (Direct) |
View |
| 2022-05-16 Purchase |
2022-05-16 1:01 pm |
Cyclo Therapeutics Inc. | CYTH | TATE JEFFREY Chief Operating Officer |
3,000 | $2.118 | $6,354 | 32,160 (Direct) |
View |
| 2022-04-28 Purchase |
2022-04-29 3:36 pm |
Cyclo Therapeutics Inc. | CYTH | TATE JEFFREY Chief Operating Officer |
2,000 | $2.6397 | $5,279 | 29,160 (Direct) |
View |
| 2022-03-29 Purchase |
2022-03-30 10:28 am |
Cyclo Therapeutics Inc. | CYTH | Sieger Markus Director |
10,000 | $2.73 | $27,300 | 81,689 (Direct) |
View |
| 2022-02-07 Purchase |
2022-02-07 3:50 pm |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
10,334 | $3.58 | $36,996 | 145,000 (Direct) |
View |
| 2022-01-24 Purchase |
2022-01-24 11:14 am |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
2,000 | $3.75 | $7,500 | 113,211 (Direct) |
View |
| 2022-01-19 Purchase |
2022-01-19 2:59 pm |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
5,000 | $3.89 | $19,450 | 134,666 (Direct) |
View |
| 2022-01-19 Purchase |
2022-01-19 2:38 pm |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
1,132 | $4 | $4,528 | 111,211 (Direct) |
View |
| 2022-01-14 Purchase |
2022-01-18 09:00 am |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
1,731 | $4 | $6,924 | 110,079 (Direct) |
View |
| 2022-01-14 Purchase |
2022-01-14 2:47 pm |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
2,137 | $4 | $8,548 | 108,348 (Direct) |
View |
| 2021-12-15 Purchase |
2021-12-15 11:20 am |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
3,000 | $3.9 | $11,700 | 106,211 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-07 Option Award |
2023-03-09 5:11 pm |
N/A 2033-03-07 |
Cyclo Therapeutics Inc. | CYTH | Lisjak Michael Eric Chief Regulatory Officer |
41,036 | $0 | 41,036 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 5:11 pm |
N/A 2033-03-07 |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
98,706 | $0 | 98,706 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 5:10 pm |
N/A 2033-03-07 |
Cyclo Therapeutics Inc. | CYTH | TATE JEFFREY Chief Operating Officer |
41,036 | $0 | 41,036 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 5:10 pm |
N/A 2033-03-07 |
Cyclo Therapeutics Inc. | CYTH | Fine Joshua M Chief Financial Officer |
41,036 | $0 | 41,036 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 5:09 pm |
N/A 2033-03-07 |
Cyclo Therapeutics Inc. | CYTH | SHANAHAN WILLIAM S Director |
3,350 | $0 | 3,350 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 5:09 pm |
N/A 2033-03-07 |
Cyclo Therapeutics Inc. | CYTH | Toig Randall M. Director |
3,350 | $0 | 3,350 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 5:08 pm |
N/A 2033-03-07 |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
3,350 | $0 | 3,350 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 5:08 pm |
N/A 2033-03-07 |
Cyclo Therapeutics Inc. | CYTH | Sieger Markus Director |
3,350 | $0 | 3,350 (Direct) |
View |
| 2022-11-08 Option Award |
2022-11-09 4:03 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
11,803 | $0 | 162,490 (Direct) |
View |
| 2022-11-08 Option Award |
2022-11-09 4:02 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Sieger Markus Director |
9,496 | $0 | 101,170 (Direct) |
View |
| 2022-11-08 Option Award |
2022-11-09 4:02 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Toig Randall M. Director |
5,097 | $0 | 56,722 (Direct) |
View |
| 2022-08-02 Option Award |
2022-08-04 4:04 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Toig Randall M. Director |
3,093 | $0 | 51,625 (Direct) |
View |
| 2022-08-02 Option Award |
2022-08-04 4:03 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Sieger Markus Director |
5,762 | $0 | 91,674 (Direct) |
View |
| 2022-08-02 Option Award |
2022-08-04 4:03 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
7,162 | $0 | 145,687 (Direct) |
View |
| 2022-05-03 Option Award |
2022-05-04 9:28 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
5,249 | $0 | 133,525 (Direct) |
View |
| 2022-05-03 Option Award |
2022-05-04 9:27 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
5,249 | $0 | 133,525 (Direct) |
View |
| 2022-05-03 Option Award |
2022-05-04 9:27 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Sieger Markus Director |
4,223 | $0 | 85,912 (Direct) |
View |
| 2022-05-03 Option Award |
2022-05-04 9:26 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Toig Randall M. Director |
2,267 | $0 | 48,532 (Direct) |
View |
| 2022-04-06 Option Award |
2022-04-07 10:00 am |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
5,000 | $2.9 | 128,276 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 4:42 pm |
N/A 2032-02-28 |
Cyclo Therapeutics Inc. | CYTH | Kjems Lise Lund Chief Medical Officer |
31,141 | $0 | 31,141 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 4:33 pm |
N/A 2022-02-28 |
Cyclo Therapeutics Inc. | CYTH | Lisjak Michael Eric Chief Regulatory Officer |
31,141 | $0 | 31,141 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 4:33 pm |
N/A 2032-02-28 |
Cyclo Therapeutics Inc. | CYTH | Fine Joshua M Chief Financial Officer |
31,141 | $0 | 31,141 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 4:32 pm |
N/A 2032-02-28 |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
74,907 | $0 | 74,907 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 4:32 pm |
N/A 2032-02-28 |
Cyclo Therapeutics Inc. | CYTH | TATE JEFFREY Chief Operating Officer |
31,141 | $0 | 31,141 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-04 12:50 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
5,000 | $3.3 | 123,276 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 09:25 am |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Toig Randall M. Director |
2,187 | $0 | 46,265 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 09:24 am |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
5,065 | $0 | 118,276 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 09:23 am |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Sieger Markus Director |
4,075 | $0 | 71,689 (Direct) |
View |